Literature DB >> 27326340

Salinomycin Hydroxamic Acids: Synthesis, Structure, and Biological Activity of Polyether Ionophore Hybrids.

Björn Borgström1, Xiaoli Huang2, Eduard Chygorin1, Stina Oredsson2, Daniel Strand1.   

Abstract

The polyether ionophore salinomycin has recently gained attention due to its exceptional ability to selectively reduce the proportion of cancer stem cells within a number of cancer cell lines. Efficient single step strategies for the preparation of hydroxamic acid hybrids of this compound varying in N- and O-alkylation are presented. The parent hydroxamic acid, salinomycin-NHOH, forms both inclusion complexes and well-defined electroneutral complexes with potassium and sodium cations via 1,3-coordination by the hydroxamic acid moiety to the metal ion. A crystal structure of an cationic sodium complex with a noncoordinating anion corroborates this finding and, moreover, reveals a novel type of hydrogen bond network that stabilizes the head-to-tail conformation that encapsulates the cation analogously to the native structure. The hydroxamic acid derivatives display down to single digit micromolar activity against cancer cells but unlike salinomycin selective reduction of ALDH(+) cells, a phenotype associated with cancer stem cells was not observed. Mechanistic implications are discussed.

Entities:  

Keywords:  ALDH+; head-to-tail conformation; hydroxamic acid derivative; salinomycin

Year:  2016        PMID: 27326340      PMCID: PMC4904257          DOI: 10.1021/acsmedchemlett.6b00079

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  39 in total

1.  The synthesis of hybrids of D-galactose with 1-deoxynojirimycin analogues as glycosidase inhibitors.

Authors:  B Gopal Reddy; Yashwant D Vankar
Journal:  Angew Chem Int Ed Engl       Date:  2005-03-18       Impact factor: 15.336

2.  Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.

Authors:  Bo Jiang; Xiaojing Huang; Hequan Yao; Jieyun Jiang; Xiaoming Wu; Siyi Jiang; Qiujuan Wang; Tao Lu; Jinyi Xu
Journal:  Org Biomol Chem       Date:  2014-02-24       Impact factor: 3.876

3.  Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-ring-modified salinomycin analogues.

Authors:  Xiaoli Huang; Björn Borgström; Linda Månsson; Lo Persson; Stina Oredsson; Cecilia Hegardt; Daniel Strand
Journal:  ACS Chem Biol       Date:  2014-05-29       Impact factor: 5.100

4.  HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells.

Authors:  Laurence Booth; Jane L Roberts; Adam Conley; Nichola Cruickshanks; Thomas Ridder; Steven Grant; Andrew Poklepovic; Paul Dent
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

5.  Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo.

Authors:  Peibin Yue; Francisco Lopez-Tapia; David Paladino; Yifei Li; Chih-Hong Chen; Andrew T Namanja; Tyvette Hilliard; Yuan Chen; Marcus A Tius; James Turkson
Journal:  Cancer Res       Date:  2015-06-18       Impact factor: 12.701

6.  Electrogenic and nonelectrogenic ion fluxes across lipid and mitochondrial membranes mediated by monensin and monensin ethyl ester.

Authors:  Yuri N Antonenko; Tatyana I Rokitskaya; Adam Huczyński
Journal:  Biochim Biophys Acta       Date:  2015-01-17

7.  Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species.

Authors:  José de Jesús Cázares Marinero; Marion Lapierre; Vincent Cavaillès; Rénette Saint-Fort; Anne Vessières; Siden Top; Gérard Jaouen
Journal:  Dalton Trans       Date:  2013-11-21       Impact factor: 4.390

8.  Synthetic modification of salinomycin: selective O-acylation and biological evaluation.

Authors:  Björn Borgström; Xiaoli Huang; Martin Pošta; Cecilia Hegardt; Stina Oredsson; Daniel Strand
Journal:  Chem Commun (Camb)       Date:  2013-11-04       Impact factor: 6.222

9.  An efficient chemical synthesis of carboxylate-isostere analogs of daptomycin.

Authors:  Sabesan Yoganathan; Ning Yin; Yong He; Michael F Mesleh; Yu Gui Gu; Scott J Miller
Journal:  Org Biomol Chem       Date:  2013-06-10       Impact factor: 3.876

10.  Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.

Authors:  Xiaoli Huang; Björn Borgström; Sebastian Kempengren; Lo Persson; Cecilia Hegardt; Daniel Strand; Stina Oredsson
Journal:  BMC Cancer       Date:  2016-02-23       Impact factor: 4.430

View more
  7 in total

1.  Expeditive Synthesis of Potent C20-epi-Amino Derivatives of Salinomycin against Cancer Stem-Like Cells.

Authors:  Dominika Czerwonka; Sebastian Müller; Tatiana Cañeque; Ludovic Colombeau; Adam Huczyński; Michał Antoszczak; Raphaël Rodriguez
Journal:  ACS Org Inorg Au       Date:  2022-01-05

2.  Rapid Access to Ironomycin Derivatives by Click Chemistry.

Authors:  Michał Antoszczak; Sebastian Müller; Ludovic Colombeau; Tatiana Cañeque; Raphaël Rodriguez
Journal:  ACS Org Inorg Au       Date:  2022-01-21

3.  Salinomycin kills cancer stem cells by sequestering iron in lysosomes.

Authors:  Trang Thi Mai; Ahmed Hamaï; Antje Hienzsch; Tatiana Cañeque; Sebastian Müller; Julien Wicinski; Olivier Cabaud; Christine Leroy; Amandine David; Verónica Acevedo; Akihide Ryo; Christophe Ginestier; Daniel Birnbaum; Emmanuelle Charafe-Jauffret; Patrice Codogno; Maryam Mehrpour; Raphaël Rodriguez
Journal:  Nat Chem       Date:  2017-05-16       Impact factor: 24.427

4.  The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin.

Authors:  Xiaoli Huang; Björn Borgström; John Stegmayr; Yasmin Abassi; Monika Kruszyk; Hakon Leffler; Lo Persson; Sebastian Albinsson; Ramin Massoumi; Ivan G Scheblykin; Cecilia Hegardt; Stina Oredsson; Daniel Strand
Journal:  ACS Cent Sci       Date:  2018-06-14       Impact factor: 14.553

Review 5.  Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers.

Authors:  Vivek Kaushik; Juan Sebastian Yakisich; Anil Kumar; Neelam Azad; Anand K V Iyer
Journal:  Cancers (Basel)       Date:  2018-09-27       Impact factor: 6.639

Review 6.  Salinomycin as a potent anticancer stem cell agent: State of the art and future directions.

Authors:  Dan Qi; Yunyi Liu; Juan Li; Jason H Huang; Xiaoxiao Hu; Erxi Wu
Journal:  Med Res Rev       Date:  2021-11-16       Impact factor: 12.388

7.  Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.

Authors:  Alicja Urbaniak; Megan R Reed; Daniel Fil; Anika Moorjani; Sarah Heflin; Michał Antoszczak; Michał Sulik; Adam Huczyński; Michalina Kupsik; Robert L Eoff; Melanie C MacNicol; Timothy C Chambers; Angus M MacNicol
Journal:  Biomed Pharmacother       Date:  2021-06-12       Impact factor: 7.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.